GSTM1 and chronic kidney disease: This study supports the recommendation in the 2008 guideline for renal anemia in CKD patients presented by the Japanese Society for Dialysis Therapy, which states that ESA therapy should be started when the Hb level is less than 11 g/dL in non-dialysis patients [14].